INCY:NASDAQ
Incyte Corp
$120.97
arrow_downward
-0.60%(-0.73) 1D
$120.02
arrow_downward
-0.79% (-0.95)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$121.89
High
$122.06
Low
$119.72
Mkt. cap
24.66B
Avg. vol.
1.82M
Volume
950.51K
P/E ratio
64.33
52-wk high
$132.60
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
Open
$121.89
High
$122.06
Low
$119.72
Mkt. cap
24.66B
Avg. vol.
1.82M
Volume
950.51K
P/E ratio
64.33
52-wk high
$132.60
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
News stories
From web sources and news partners
Investing.com Canada
·
1 hour ago
Form 144 INCYTE CORPORATION For: 14 November By Investing.com
GuruFocus
·
9 hours ago
Incyte (INCY) Halts Phase 3 MAESTRA-3 Trial to Refocus Clinical Development
Investing.com Canada
·
10 hours ago
Form 8K Incyte Corporation For: 13 November By Investing.com
Yahoo Finance
·
11 hours ago
Incyte Corporation (INCY) Stock Forecasts
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorHealth Care
IndustryBiotechnology
Websiteincyte.com